Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its profit view.
Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat
Licensing
08:55 AM ET 07/16/2026
Abbott Laboratories (ABT) stock jumped early Thursday after the healthcare behemoth reported adjusted earnings of $1.31 per share on $12.59 billion in second-quarter sales. On average, analysts polled by FactSet expected Abbott Labs to earn $1.28 a share while on $12.52 billion in sales. During the same three months in 2025, Abbott posted profit of $1.26 a share and reported…
Why Is Abbott Stock Skyrocketing Thursday? - Abbott Laboratories (NYSE:ABT)
Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised
Abbott Laboratories Up Over 11%, on Pace for Largest Percent Increase Since July 2002 — Data Talk
UnitedHealth, Abbott Laboratories And 3 Stocks To Watch - UnitedHealth Group (NYSE:UNH)
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its full-year profit outlook. Read…
Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year…
Abbott Laboratories (ABT) is currently at $99.59, up $10.32 or 11.56%
Top Wall Street analysts changed their outlook on top names. See the latest analyst ratings and coverage on stocks like ABT,…
AbbVie, Inc. (ABBV) is currently at $231.34, up $14.86 or 6.86%
ABM Industries (NYSE: ABM) stock jumps 6.7% after beating Q2 estimates & confirming strong fiscal 2026 earnings guidance.
